Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Situ Clinical Trial Investigating the Ability of BlueCheck to Detect and Monitor Active Carious Lesions and Their Remineralization

NCT07100626 is registered in ClinicalTrials.gov with Incisive Technologies Pty Ltd as lead sponsor.

NCT NCT07100626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07100626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Situ Clinical Trial Investigating the Ability of BlueCheck to Detect and Monitor Active Carious Lesions and Their Remineralization
Lead sponsor
Incisive Technologies Pty Ltd
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 24, 2025
Completion date
January 31, 2026
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dental caries